| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/06/2013 | CN101993281B Culture medium of ganoderma capense (Lloyd) Teng fungus for preparing Baozhi glycopeptide injection |
| 03/06/2013 | CN101983968B Preparation method of sepia oligopeptide by enzymatic hydrolysis |
| 03/06/2013 | CN101914043B Method for synchronously extracting and preparing taurine, biological zinc and polypeptide from oysters |
| 03/06/2013 | CN101884783B Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof |
| 03/06/2013 | CN101717806B Integrated peptidoglycan and preparation method thereof |
| 03/05/2013 | US8389793 Methods for increasing the diversity of monoclonal antibodies produced against an antigen |
| 03/05/2013 | US8389694 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (I) interferon producing cells |
| 03/05/2013 | US8389693 Stable and soluble antibodies inhibiting TNFα |
| 03/05/2013 | US8389692 Anti-platelet membrane glycoprotein VI monoclonal antibody |
| 03/05/2013 | US8389691 Antibodies with immune effector activity and that internalize in endosialin-positive cells |
| 03/05/2013 | US8389690 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/05/2013 | US8389685 Vector encoding a plasmid replication protein and use thereof |
| 03/05/2013 | US8389681 Methods for production of proteins |
| 03/05/2013 | US8389676 Biotinylation tag peptides |
| 03/05/2013 | US8389480 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| 03/05/2013 | US8389262 Subtilase variants having altered immunogenicity |
| 03/05/2013 | US8389261 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 03/05/2013 | US8389250 Methods for producing methionine by culturing a microorganism modified to enhance production of cysteine |
| 03/05/2013 | US8389242 Process for producing Apo2L |
| 03/05/2013 | US8389241 Enzyme that catalyzes a peptide-forming reaction from a carboxy component and an amine component, microbe producing the same, and a method of producing a dipeptide using the enzyme or microbe |
| 03/05/2013 | US8389240 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester |
| 03/05/2013 | US8389239 Enhanced expression and stability regions |
| 03/05/2013 | US8389238 Long-term in vivo transgene expression |
| 03/05/2013 | US8389237 Antibodies against RAMP3 |
| 03/05/2013 | US8389236 Assay |
| 03/05/2013 | US8389235 Methods for specifically selecting antibody-producing cells |
| 03/05/2013 | US8389227 Method for diagnosing cancers expressing the HER2 receptor or its truncated variants |
| 03/05/2013 | US8389207 Methods for identifying candidate fat-mobilizing agents |
| 03/05/2013 | US8388980 Yeast-based therapeutic for chronic hepatitis C infection |
| 03/05/2013 | US8388975 Cancer antigen peptides derived from WT1 |
| 03/05/2013 | US8388973 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 03/05/2013 | US8388971 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
| 03/05/2013 | CA2659180C Trichoderma reesei swollenin protein and encoding dna sequences |
| 02/28/2013 | WO2013028996A1 Self-assembled bead-based multiplexed assay for antigen-specific antibodies |
| 02/28/2013 | WO2013028635A1 Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as a antibodies in transformed microbes such as pichia pastoris |
| 02/28/2013 | WO2013028233A1 Peg-interferon lambda 1 conjugates |
| 02/28/2013 | WO2013027802A1 Novel anti-ddr1 antibody having anti-tumor activity |
| 02/28/2013 | WO2012162705A3 Cell and gene based methods to improve cardiac function |
| 02/28/2013 | US20130055469 Pesticidal proteins and methods for their use |
| 02/28/2013 | US20130053551 Cation and anion exchange chromatography method |
| 02/28/2013 | US20130053550 Yeast strains producing mammalian-like complex n-glycans |
| 02/28/2013 | US20130053546 Use of Anticoagulants in the Production of Recombinant Proteins in the Milk of Transgenic Animals |
| 02/28/2013 | US20130053544 Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds |
| 02/28/2013 | US20130053267 Cell free translation system for compound screening and related uses |
| 02/28/2013 | US20130052686 Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
| 02/28/2013 | US20130052685 Prevention and treatment of complement-associated eye conditions |
| 02/28/2013 | US20130052684 Method for producing useful substances by a recombinant actinomycete, streptomyces species |
| 02/28/2013 | US20130052683 Production of galactosylated n-glycans in plants |
| 02/28/2013 | US20130052682 Processing biomass |
| 02/28/2013 | US20130052660 Method for detecting protein-protein interactions in cells |
| 02/28/2013 | US20130052226 Compositions and methods for preventing or treating a human parvovirus infection |
| 02/28/2013 | US20130052216 Targeted heterologous antigen presentation on calicivirus virus-like particles |
| 02/28/2013 | US20130052213 Novel immunomodulatory peptide |
| 02/28/2013 | US20130052202 HIGH AFFINITY, ANTI-HUMAN IgE ANTIBODIES |
| 02/28/2013 | US20130052200 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 02/28/2013 | US20130052197 Novel anti-cd98 antibody and use thereof |
| 02/28/2013 | CA2845579A1 Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris |
| 02/27/2013 | EP2562188A2 Compositions and methods for diagnosing and treating cancer |
| 02/27/2013 | EP2561086A1 System for the in vitro transcription and translation of membrane proteins |
| 02/27/2013 | EP2561065A2 Cell culture medium comprising small peptides |
| 02/27/2013 | EP2093286B1 Multi-chain eukaryotic display vectors and uses thereof |
| 02/27/2013 | CN102943102A Method for biosynthesizing virginiamycin by streptomycete |
| 02/27/2013 | CN102943101A Method for producing enramycin by fermenting |
| 02/27/2013 | CN102943077A Method for preparing thanatin based on escherichia coli prokaryotic expression system |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN102942628A Co-production method for extracting bioactive substances from pig blood |
| 02/27/2013 | CN102940551A High-concentration collagen sponge wound protection paste and preparation method thereof |
| 02/27/2013 | CN102429891B Method for preparing low-molecular-weight sheep bone collagen polypeptide calcium chelate microcapsules |
| 02/27/2013 | CN101948896B Integrated preparation method of multi-function milk casein active peptides |
| 02/27/2013 | CN101928742B Whey protein active peptide with antioxidant activity and preparation method thereof |
| 02/27/2013 | CN101921336B Monoclonal antibody against human alpha1 acid glycoprotein and preparation method thereof |
| 02/27/2013 | CN101748078B Novel Bacillus amyloliquefaciens strain and application thereof |
| 02/27/2013 | CN101712975B Deodorized fish peptide and preparation method thereof |
| 02/27/2013 | CN101018860B Flavivirus vaccine |
| 02/26/2013 | US8383799 Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
| 02/26/2013 | US8383788 For therapy of cancer or tumorous growth |
| 02/26/2013 | US8383779 Human antibodies that bind mesothelin, and uses thereof |
| 02/26/2013 | US8383775 Cytokine zalpha11 ligand |
| 02/26/2013 | US8383774 Collectin fusion proteins comprising TNF or trail |
| 02/26/2013 | US8383766 Zinc finger protein for use as transcriptional modulator |
| 02/26/2013 | US8383388 for oral administration; exhibit increased protein stability; exhibit increased stability in the bloodstream, following oral administration, and/or under storage conditions |
| 02/26/2013 | US8383366 Enhanced protein expression in Bacillus |
| 02/26/2013 | US8383365 Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives |
| 02/26/2013 | US8383364 Inducible expression systems |
| 02/26/2013 | US8383358 Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy |
| 02/26/2013 | US8383112 Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases |
| 02/26/2013 | US8383110 Modulators of Candida hyphal morphogenesis and uses thereof |
| 02/26/2013 | US8383096 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine |
| 02/26/2013 | CA2542035C Process for producing antithrombin iii composition |
| 02/26/2013 | CA2493822C Methods and compositions for targeting secretory lysosomes |
| 02/26/2013 | CA2389644C A novel polypeptide hormone phosphatonin |
| 02/26/2013 | CA2380302C Production of proteins by autoproteolytic cleavage |
| 02/26/2013 | CA2350335C Host cells expressing recombinant human erythropoietin |
| 02/26/2013 | CA2327586C Fap.alpha.-specific antibody with improved producibility |
| 02/26/2013 | CA2324648C Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 02/26/2013 | CA2324381C An integrin heterodimer and a subunit thereof |
| 02/21/2013 | WO2013025779A1 Anti-b7-h4 antibodies and their uses |
| 02/21/2013 | WO2013025598A1 Degranulation indicator and methods of use thereof |
| 02/21/2013 | WO2013023938A1 Reduction of culture viscosity by manganese addition |
| 02/21/2013 | US20130046081 Fully human monoclonal antibody to vegf, preparation method and use thereof |